Prospective, randomized, open-label,clinical trial comparing the effects of febuxostat and allopurinol on blood urate levels, endothelial function and makers for obesity/oxidative stress/chronic kidney diseases
Not Applicable
- Conditions
- Hyperuricemia
- Registration Number
- JPRN-UMIN000011741
- Lead Sponsor
- ational Defense Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 31
Inclusion Criteria
Not provided
Exclusion Criteria
1) Allergy against febuxostat/allopurinol 2) History of stroke, acute coronary syndrome or any cardiovascular diseases needed for inpatient-treatments within 6 months 3) Either level of aspartate aminotransaminase or alanine aminotransferase exceeds three-fold of the normal limits. 4) eGFR<30ml/min./1.73m2 5) Subjects whose doctor in charge do not agree to join the trial
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method